BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration’s (FDA) newly announced plan to reduce reliance on ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Emulate, Inc. today announced that it recently formed a research collaboration with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson ...
Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...
Technology developed for NASA’s Artemis II moon mission may one day help improve medical treatments for people on Earth.
insights from industryJim CorbettCEOEmulate, Inc. In this interview, NewsMedical speaks with Jim Corbett, CEO of Emulate, Inc., about the development and impact of the AVA Emulation System and how it ...
Emulate and Laboratory Corp. of America’s Covance unit have formed a partnership to assess “organs on chips” technology for preclinical drug evaluation. Emulate will bring to the partnership its ...
As drug developers seek models that better predict human outcomes, Organ-Chip systems have gained traction as a physiologically relevant alternative to traditional approaches. These microengineered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results